Trial Clinical Marketing Communications - GA Cobb, Kennesaw 30144

Trial Clinical Marketing Communications entered the industry of Communications in 2008 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 517919, which describes it as a Communications. For further clarification, the SIC classifies this business under the code 4899 and described it as a Communications. The business provides service to the BOTH market.

To acquire more information, please contact Ken Wallace by calling (786) 247-5876 during business hours. You can also write to the business’ Single Location at 1350 Wooten Lake Road Nw, Kennesaw, Georgia GA 30144. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Trial Clinical Marketing Communications
Representative: Ken Wallace
Place of Business: 1350 Wooten Lake Road Nw, Kennesaw, GA 30144
Contact Number: (786) 247-5876
Type of Service: Communications
SIC Number: 4899
NAICS Number: 517919
Locality: Single Location
Market Type: B2B & B2C
Began: 2008
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Trial Clinical Marketing Communications is a company operating from Cobb, Georgia providing professional Communications and relevant BOTH variables. It was founded in 2008 and registered with the SIC code 4899 as Communications, and with the NAICS code 517919 as Communications.

With a current employee count of 1 to 4, Trial Clinical Marketing Communications has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Ken Wallace at (786) 247-5876 for related queries, or to locate its Single Location using the coordinates 34.06061,-84.590976.

The Single Location can also be found at the street address 1350 Wooten Lake Road Nw in Kennesaw, Georgia 30144 and can be engaged online through the company website at , the company Twitter , and Facebook page .